New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 22, 2013
06:42 EDTTRIBTrinity Biotech downgraded to Neutral from Buy at Roth Capital
Roth Capital downgraded Trinity Biotech due to valuation. Price target is $15.50.
News For TRIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 23, 2014
09:06 EDTTRIBTrinity Biotech reports Q3 EPS 19c, consensus 20c
Reports Q3 revenue $27.2M, consensus $27.3M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use